Abortion Pill Access Threatened as Justices Take Narrow Appeal

The US Supreme Court’s decision to review only part of the appeal over the abortion drug mifepristone is a partial win for abortion advocates, as the justices declined to consider a challenge to the decades-old approval of the drug.

But legal experts note that even upholding lower court restrictions on the drug’s access could prove perilous for people seeking reproductive services and the medical professionals tasked with providing them.

The justices on Wednesday agreed to hear appeals from the Food and Drug Administration and Danco Laboratories, the maker of the name brand version of the abortion drug mifepristone, regarding ...